DOULEUR ET PERSONNE ÂGÉE - Institut upsa de la douleur

SPÉCIFICITÉS DE LA PRISE EN CHARGE ANTALGIQUE DE LA DOULEUR CHEZ LA PERSONNE ÂGÉE48. Griessinger N, Sitti R, Likar R. Transdermal buprenorphine in clinical practice – a postmarketingsurveillance study in 13,179 patients. Curr Med Res Opin 2005; 21:1147-1156.49. Dagtekin O, Gerbershagen HJ, Wagner W, Petzke F, Radbruch L, Sabatowski R. Assessingcognitive and psychomotor performance under long-term treatment with transdermalbuprenorphine in chronic noncancer pain patients. Anesth Analg 2007; 105:1442-1448.50. Payne R. Opioid pharmacotherapy. In: Berger AM, Portenoy RK, Weissman DE, editors.Principles and Practice of Palliative Care and Supportive Oncology, 2nd edition,Philadelphia: Lippincott Williams & Wilkins, 2002, pp 68-83.51. Purdue Pharma, OxyContin (monograph), 2001.52. Pisani MA, Murphy TE, Araujo KLB, Slattum P, Van Ness PH, Inouye SK. Benzodiazepineand opioid use and the duration of intensive care unit delirium in an older population.Crit Care Med 2009; 37:177-183.53. Fong HK, Sands LP, Leung JM. The role of postoperative analgesia in delirium and cognitivedecline in elderly patients: a systematic review. Anesth Analg 2006; 12:1255-1266.54. Duggleby W, Lander J. Cognitive status and postoperative pain: older adults. J PainSympt Manage 1994; 9:19-27.55. Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioidanalgesics on the development of delirium following hip fracture. J Gerontol Med Sci2003; 58A:76-81.56. Shorr RI, Griffin MR, Daugherty J, Ray WA. Opioid analgesics and the risk of hipfracture in the elderly: codeine and propoxyphene. J Gerontol Med Sci 1992; 47:M111-M115.57. Weiner D, Hanlon JT, Studenski SA. Effects of central nervous system polypharmacy onfalls liability in community-dwelling elderly. Gerontol 1998; 44:217-221.58. Lussier D, Beaulieu P. Toward a rational taxonomy of analgesic drugs. In: Beaulieu P,Lussier D, Porreca F, Dickenson AH, eds. Pharmacology of Pain. Seattle: IASP Press, 2010,pp. 27-40.59. Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications forantidepressants. J Clin Pharmacol 2005; 45: 1106-1122.60. Watson CPN, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline inpostherpetic neuralgia: a randomized trial. Neurol 1998; 51:1166-1171.61. Raskin J, Wiltse CG, Siegal A, et al. Efficacy of duloxetine on cognition, depression, andpain in elderly patients with major depressive disorder: an 8-week, double-blind,placebo-controlled trial. Am J Psychiatr 2007;164:900-909.62. Raskin J, Xu JY, Kadasz DK. Time to response for duloxetine 60 mg once daily versusplacebo in elderly patients with major depressive disorder. Intern Psychogeriatr 2007;20:309-327.108